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Abstract
Background: Asian Indians display a high prevalence of diseases linked to changes in diet and
environment that have arisen as their lifestyle has become more westernized. Using 1200 genome-
wide polymorphisms in 432 individuals from 15 Indian language groups, we have recently shown
that: (i) Indians constitute a distinct population-genetic cluster, and (ii) despite the geographic and
linguistic diversity of the groups they exhibit a relatively low level of genetic heterogeneity.
Results: We investigated the prevalence of common polymorphisms that have been associated
with diseases, such as atherosclerosis (ALOX5), hypertension (CYP3A5,  AGT,  GNB3), diabetes
(CAPN10, TCF7L2, PTPN22), prostate cancer (DG8S737, rs1447295), Hirschsprung disease (RET),
and age-related macular degeneration (CFH, LOC387715). In addition, we examined polymorphisms
associated with skin pigmentation (SLC24A5) and with the ability to taste phenylthiocarbamide
(TAS2R38). All polymorphisms were studied in a cohort of 576 India-born Asian Indians sampled in
the United States. This sample consisted of individuals whose mother tongue is one of 14 of the 22
"official" languages recognized in India as well as individuals whose mother tongue is Parsi, a cultural
group that has resided in India for over 1000 years. Analysis of the data revealed that allele
frequency differences between the different Indian language groups were small, and interestingly
the variant alleles of ALOX5 g.8322G>A and g.50778G>A, and PTPN22 g.36677C>T were present
only in a subset of the Indian language groups. Furthermore, a latitudinal cline was identified both
for the allele frequencies of the SNPs associated with hypertension (CYP3A5, AGT, GNB3), as well
as for those associated with the ability to taste phenylthiocarbamide (TAS2R38).
Conclusion: Although caution is warranted due to the fact that this US-sampled Indian cohort may
not represent a random sample from India, our results will hopefully assist in the design of future
studies that investigate the genetic causes of these diseases in India. Our results also support the
inclusion of the Indian population in disease-related genetic studies, as it exhibits unique genotype
as well as phenotype characteristics that may yield new insights into the underlying causes of
common diseases that are not available in other populations.
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India is currently the second most populous country in
the world after China with a population of 1,087 million
that is predicted to expand to 1,628 million by the year
2050 [1]. The high prevalence of endogamy and relatively
low admixture present in the population distinguishes
Asian Indians (from the subcontinental region compris-
ing India, Pakistan, Bangladesh and Sri Lanka) from most
other populations presently used in genetic studies [2]. As
the country is becoming more westernized both in diet
and lifestyle, the prevalence of diseases associated with
these lifestyle changes is increasing.
The languages of India belong to four major families:
Indo-Aryan (a branch of the Indo-European family), Dra-
vidian, Austroasiatic, and Sino-Tibetan, with the over-
whelming majority of the population speaking languages
belonging to the first two families [3]. The 1981 census –
the last census to tabulate languages – reported 112
mother tongues with more than 10,000 speakers and
almost 1 million people speaking other languages. The
Indian constitution recognizes 22 official Indian lan-
guages. They are Assamese, Bengali, Bodo, Dogri,
Gujarati, Hindi, Kannada, Kashmiri, Konkani, Maithili,
Malayalam, Manipuri, Marathi, Nepali, Oriya, Punjabi,
Sanskrit, Santhali, Sindhi, Tamil, Telugu, and Urdu. Of
the official languages, about 43 percent of the population
speaks Hindi as their mother tongue. Telugu, Bengali,
Marathi, and Tamil rank next, each the mother tongue of
about 4 to 5 percent; Urdu, Gujarati, Malayalam, Kan-
nada, and Oriya are claimed by between 2 and 3 percent;
Bhojpuri, Punjabi, and Assamese by 1 to 2 percent; and all
other languages by less than 1 percent each. Pertinent to
this study, with the exception of Hindi, which is the pri-
mary language spoken in several north Indian states, each
of the other languages is spoken by individuals with ori-
gins from a distinct Indian state [3] and hence, each corre-
sponds to a geographically defined region within India.
The Parsis are a member of the close-knit Zoroastrian
community found primarily in the Indian state of Gujarat.
Although the Parsis of India are descendents from Persian
Zoroastrians who emigrated to the Indian subcontinent
from Persia over 1,000 years ago [4-6], they no longer
have social or familial ties to Persians, and do not share
language or recent history with them. Mitochondrial and
Y-chromosome analyses suggest that since their arrival in
India, the Parsis have integrated themselves into Indian
society through a male-mediated migration of their ances-
tors who admixed with local females [7,8]. However, they
have simultaneously maintained their own ethnic iden-
tity, making the Parsi community both Indian in terms of
national affiliation, language and history, but not typi-
cally Indian in terms of consanguinity or cultural, behav-
ioral and religious practices.
Large inter-ethnic variation is known for a
number of common conditions, which may
be due, in part, to differences in risk allele frequencies that
are the result of either population structure, migration, or
the action of natural selection on the risk variants them-
selves [9]. Because selective pressures may vary with geog-
raphy and other environmental variables, detectable
patterns of geographic variation may sometimes be
observed in disease alleles. Recent population structure
analysis using 1200 genome-wide polymorphisms in 432
individuals from 15 Indian language groups has shown
that Indians constitute a distinct population cluster and
that despite the geographic and linguistic diversity of the
groups, they exhibit a low level of genetic differentiation
[10].
Metabolic disorders have been found to have a dispropor-
tionately high prevalence in the Indian population, a phe-
nomenon which is likely associated with the increasing
westernization of India. For example, many studies have
shown that the prevalence of coronary artery disease
(CAD) in individuals of Indian origin is currently much
higher than in other ethnic groups and is even increasing
[11-17]. It is also currently estimated that 18% of the
Indian population suffer from hypertension, one of the
major risk factors associated with CAD, and that the prev-
alence of hypertension is also increasing within this pop-
ulation [18]. However, this prevalence is comparable to
that in other worldwide populations (15.0–40.0%) [19].
Type-2 diabetes is now reaching epidemic proportions in
India, most prominently in urban Indians where there has
been a very steep increase in prevalence over the last dec-
ade from 8.3% in 1992, 11.6% in 1997, to 15.5% in 2005
[20-23]. Other diseases are also found at varying frequen-
cies in the Indian population including Hirschsprung dis-
ease [24,25], age-related macular degeneration (AMD)
[26,27], prostate cancer [28,29], and type-1 diabetes
[30,31]. However, despite the high prevalence of com-
mon disorders and the large population within which to
study them, most modern genetic studies have not incor-
porated Indian populations.
In the present study, we have investigated the prevalence
of common polymorphisms that have recently been
reported to be risk factors for atherosclerosis, hyperten-
sion, diabetes, prostate cancer, Hirschsprung disease, and
age-related macular degeneration (Table 1) in a cohort of
576 India-born Asian Indians sampled in the United
States. This cohort consists of individuals whose mother
tongue is one of 14 of the 22 "official" languages recog-
nized in India, as well as individuals whose mother
tongue is Parsi. We have also investigated variation in the
TAS2R38 bitter taste receptor, associated with the ability
to taste phenylthiocarbamide (PTC), and in the SLC24A5
gene, associated with variation in human skin pigmenta-BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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tion (Table 1). The prevalence of these diseases/traits [32-
43] and the risk-associated variant alleles of these poly-
morphisms (see Additional file 1) have been reported to
vary between populations/ethnicities, suggesting that
their influence may also vary between populations. The
etiology of most cases of CAD [44], type-1 [45] and type-
2 [46] diabetes, hypertension [47], prostate cancer [48],
and AMD [49] are complex and are likely caused by the
combined effect of genes and environment. However, the
relative contribution of genes versus environment to the
diseases/traits and the degree of genetic heterogeneity are
likely very different for the different diseases/traits consid-
ered in this paper. Whilst we have investigated the preva-
lence of these minor alleles within this Indian cohort and
compared the frequencies to those of other populations,
we have not addressed the potential impact of environ-
mental factors that may differ between these populations.
This study will hopefully aid in the design of future
genetic studies investigating the underlying causes of
these diseases in India.
Results
We have examined the variation of 19 common polymor-
phisms (Table 1) associated with diseases/traits in a col-
lection of 576 individuals of Indian descent sampled in
the United States that represent 14 of the 22 official or
scheduled Indian languages as well as one additional cul-
tural group (Parsi; Figure 1). These individuals are part of
an expanded cohort that represents 15 groups defined by
language and that was used in a previous population-
genetic study [10]. The allele frequencies of these 19 com-
mon polymorphisms in the Indian cohort can be found in
Tables 2, 3, 4; for genotype frequencies see Additional file
2, Tables S1–3.
Indian language groups
All of the polymorphisms genotyped in our Indian cohort
were found to be in Hardy-Weinberg equilibrium (HWE;
Tables 2, 3, &4), except for the ALOX5 g.20C>T polymor-
phism which gave an HWE constant of 0.016 (p-value
0.014). However, when corrected for multiple testing
using a Bonferroni correction, this deviation becomes
insignificant (corrected p-value 0.266).
Computations of FST suggested that there were no signifi-
cant minor allele frequency (MAF) differences between
the language groups (Tables 2, 3, &4). This is in agreement
with a recent population structure analysis of this Indian
cohort that found that the different language groups
exhibited a low level of genetic differentiation [10]. There-
fore, when comparing the MAF of these polymorphisms
in this Indian cohort with their frequency in other popu-
lations, we grouped the MAFs of these polymorphisms in
the Indian language groups into a single comparative
group. Of those polymorphisms with MAF data reported
in other populations (see Additional file 1, Tables S4–20),
most had significant differences in frequency with our
Indian cohort (Tables 2, 3, &4).
Patterns in the variation of the MAF of several of the 19
polymorphisms were visible between some of the lan-
guage groups (Tables 2, 3, &4). Of note was the Kashmiri
group, which had significantly higher MAFs than the
other groups for the CAPN10  g.4834T>C and TCF7L2
g.98386G>T SNPs associated with type-2 diabetes risk
(Table 2). Furthermore, considering the hypertension-
associated SNPs, whilst the Kashmiri group had a signifi-
cantly lower MAF for the CYP3A5 g.6980G>A SNP com-
pared to the other groups, this language group also had
the highest MAF for the AGT g.802C>T SNP and the sec-
ond highest MAF for the GNB3g.4423C>T SNP (Table 2).
Interestingly, whilst the Kashmiri group also had the high-
est MAFs for all three TAS2R38 SNPs associated with the
ability to taste PTC (Table 4), the Kannada group had the
lowest MAF for all three TAS2R38 SNPs. It was also note-
worthy that the Oriya group had a significantly higher
MAF of the rs1447295 SNP associated with prostate can-
cer risk than the other groups (Table 3), but this higher
prevalence was not reflected in the DG8S737 microsatel-
lite allele frequencies that are also associated with prostate
cancer risk.
Hypertension
The frequency of the CYP3A5 g.6980G>A [50,51], AGT
g.802C>T [50], and GNB3  g.825C>T [52-54] polymor-
phisms have been reported to vary significantly between
different populations/ethnicities in a cline that correlates
with the latitudinal variation of the populations
[50,55,56]. To investigate how this Indian cohort and its
language groups fit into this correlation, the MAFs of the
individual groups were plotted against absolute latitude
together with the MAFs of the other known populations
previously investigated with regard to the latitudinal cline
(Figure 2; see Additional file 1, Tables S4–6). The MAFs of
the Indian language groups for the CYP3A5 g.6980G>A
SNP were found to follow the pattern of the other popu-
lations (Figure 2A). Accordingly, the correlation of allele
frequency with latitude, as measured by ρ and r2,
remained similarly high whether or not the Indian data
were included (Table 5). A corresponding correlation was
not found for the AGT g.802C>T SNP, for which the lan-
guage groups were clustered largely below the other pop-
ulations (Figure 2B). This resulted in an appreciable
reduction in ρ and r2 with the inclusion of the Indian data
(Table 5), but the correlation remained significant at the
0.01 level. For the GNB3 g.825C>T SNP, the MAFs of the
language groups largely cluster slightly below those of the
other populations (Figure 2C). However, there was a sub-
stantial reduction of both ρ and r2 when the Indian dataBMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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were included (Table 5), reducing the significance of the
correlation to the 0.05 level.
Atherosclerosis
Whilst deviation away from the common 5-allele of the
ALOX5 promoter microsatellite (ALOX5P) has been pre-
viously associated with an increased risk of atherosclerosis
[57], allelic variation at the three ALOX5 coding SNPs
(g.20C>T; g.8322G>A; g.50778G>A) has not. Haplotype
analysis of ALOX5P and these three ALOX5 SNPs in this
Indian cohort found that they were in strong LD, with a D'
close to 1 (data not shown). However, their squared cor-
relation (r2) was found to vary (Table 6). The 4-repeat
allele of ALOX5P was found to be strongly correlated with
the minor T-allele of the g.20C>T SNP, and the common
5-repeat allele was strongly correlated with the major C-
allele of the g.20C>T SNP. The 3-repeat allele of the pro-
moter repeat polymorphism was also found to be in mod-
erate correlation with the major G-allele of the
g.50778G>A SNP. In agreement with this correlation and
with the allele frequencies, the most common haplotype
of the ALOX5P promoter variant and the coding ALOX5
SNPs (g.20C>T; g.8322G>A; g.50778G>A) in the Indian
population was 5CGG. The frequency of this haplotype
was four times that of the second most common haplo-
type, which combined the 4-repeat allele of ALOX5P with
the minor allele of the g.20C>T SNP and the major allele
of the g.8322G>A and g.50778G>A SNPs (Table 7). Over
half of the Indian cohort was homozygous for the 5CGG
haplotype (Table 8) and a further third were hetero-
zygous, of which 3.3% also possessed a second haplotype
containing the 5-repeat allele of ALOX5P (Table 9). Two
Table 1: Investigated polymorphisms and their associated diseases.
Gene Name Nucleotide Change Protein Change NCBI Acc. # Phenotype Reference
AGT g.802C>T M235T rs699 Hypertension [100]
CYP3A5 g.6980G>A IVS4 rs776746 Hypertension [101]
GNB3 g.4423C>T S275S rs6489738 Hypertension [53]
ALOX5 (5'-GGGCGG-3')3–8 promoter none Athersclerosis [57]
ALOX5 g.20C>T T7T rs4987105 Athersclerosis
ALOX5 g.8322G>A T90T rs2228064 Athersclerosis
ALOX5 g.50778G>A E243K rs2228065 Athersclerosis
CAPN10 g.4834T>C IVS3 rs2975760 Type-2 diabetes [102]
TCF7L2 g.98386G>T IVS4 rs12255372 Type-2 diabetes [103]
PTPN22 g.36677C>T R620W rs2476601 Type-1 diabetes [104]
Intragenic (5'-AC-3')13–30 none DG8S737 Prostate Cancer [58]
Intragenic C>A none rs1447295 Prostate Cancer [58]
CFH g.37989T>C Y402H rs1061170 Age-related macular degeneration [105-107]
LOC387715 g.205G>T A69S rs10490924 Age-related macular degeneration [108]
RET g.9349G>A IVS1 rs2435357 Hirschsprung disease [109]
TAS2R38 g.144G>C A49P rs713598 ability to taste PTC [59]
TAS2R38 g.784C>T A262V rs1726866 ability to taste PTC [59]
TAS2R38 g.885A>G I296V rs10246939 ability to taste PTC [59]
SLC24A5 g.13233G>A A111T rs1426654 Skin pigmentation [110]
Sampled language groups, their sample sizes, and their geo- graphic origins within India Figure 1
Sampled language groups, their sample sizes, and their geo-
graphic origins within India.B
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) Table 2: Allele frequencies of the polymorphisms associated with the metabolic disorders of diabetes, hypertension, and atherosclerosis.
Diabetes Hypertension Atherosclerosis
Gene Name: PTPN22 CAPN10 TCF7L2 CYP3A5 AGT GNB3 ALOX5 ALOX5 ALOX5 ALOX5
Nucleotide Change: g.36677C>T g.4834T>C g.98386G>T g.6980G>A g.802C>T g.4423C>T MS (5'-GGGCGG-3' starting at -145) g.20C>T g.8322G>A g.50778G>A
n ° N T C T A T T 34567 8 T A A
Mother Tongue
Assamese 26 26.00 0.000 0.220 0.280 0.220 0.400 0.280 0.000 0.160 0.800 0.040 0.000 0.000 0.140 0.000 0.020
Bengali 27 23.00 0.017 0.224 0.138 0.207 0.414 0.293 0.000 0.276 0.655 0.069 0.000 0.000 0.276 0.017 0.000
Gujarati 181 23.00 0.000 0.167 0.167 0.313 0.229 0.396 0.000 0.167 0.792 0.042 0.000 0.000 0.188 0.000 0.000
Hindi 29 30.30 0.012 0.209 0.244 0.221 0.395 0.279 0.000 0.186 0.767 0.047 0.000 0.000 0.186 0.012 0.000
Kannada 24 15.00 0.000 0.268 0.214 0.339 0.339 0.411 0.000 0.179 0.732 0.089 0.000 0.000 0.179 0.036 0.000
Kashmiri 24 32.44 0.000 0.320 0.480 0.080 0.480 0.420 0.000 0.180 0.800 0.020 0.000 0.000 0.160 0.020 0.000
Konkani 43 15.00 0.000 0.115 0.192 0.346 0.308 0.288 0.000 0.080 0.860 0.060 0.000 0.000 0.096 0.058 0.000
Malayalam 25 10.00 0.000 0.130 0.222 0.333 0.426 0.315 0.000 0.148 0.759 0.093 0.000 0.000 0.148 0.000 0.000
Marathi 26 20.00 0.000 0.278 0.315 0.481 0.333 0.259 0.000 0.111 0.778 0.111 0.000 0.000 0.111 0.000 0.000
Marwari 25 27.00 0.006 0.265 0.243 0.265 0.423 0.296 0.008 0.186 0.758 0.044 0.000 0.003 0.193 0.019 0.003
Oriya 27 20.00 0.019 0.192 0.231 0.250 0.308 0.346 0.000 0.231 0.692 0.077 0.000 0.000 0.231 0.000 0.000
Parsi 25 19.00 0.020 0.280 0.180 0.240 0.320 0.440 0.000 0.240 0.660 0.100 0.000 0.000 0.240 0.020 0.000
Punjabi 28 30.40 0.017 0.155 0.241 0.259 0.379 0.345 0.034 0.259 0.690 0.017 0.000 0.000 0.241 0.000 0.017
Tamil 29 11.00 0.018 0.161 0.321 0.143 0.429 0.393 0.018 0.232 0.714 0.036 0.000 0.000 0.232 0.054 0.018
Telugu 28 16.00 0.000 0.229 0.271 0.167 0.354 0.229 0.000 0.229 0.688 0.063 0.021 0.000 0.229 0.000 0.000
FST 0.016 0.008 0.002 0 0.011 0.010 0.006 0.013 0.009 0.013
p-value 1 1 1 1 1 1 1 1 1 1
Gender
Female 237 0.002 0.241 0.241 0.295 0.390 0.316 0.008 0.191 0.733 0.066 0.002 0 0.192 0.017 0.006
Male 339 0.013 0.224 0.254 0.236 0.385 0.320 0.004 0.192 0.753 0.049 0 0.001 0.193 0.016 0.003
FST 0 0.041 0.046 0 0.052 0.052 0 0.052 0.052 0.037
p-value 1 0.839 0.830 1 0.820 0.820 1 0.819 0.820 0.847
Population
Cohort 576 0.009 0.231 0.248 0.260 0.387 0.319 0.006 0.192 0.745 0.056 0.001 0.001 0.193 0.016 0.004
Standard Error 0.002 0.016 0.021 0.025 0.017 0.017 0.003 0.014 0.015 0.007 0.001 1.85 × 10-4 0.013 0.005 0.002
HWE Constant 4.98 × 10-5 0.003 0.001 0.013 0.004 0.001 0.009 0.016 2.50 × 10-4 1.94 × 10-5
p-value 1 0.720 1 0.100 0.658 1 0.213 0.014 11
Welch modified t-test:
Africa 5.57 × 10-9 8.44 × 10-3 4.55 × 10-10 0.151 0.172
Europe 7.16 × 10-6 0.003 0.790 3.19 × 10-4 1.57 × 10-4 0.036 0.724 0.067
Middle East 1.94 × 10-9 0.007
Central/South Asia 0.006 4.65 × 10-5 1.16 × 10-6 4.89 × 10-14 0.432 1.37 × 10-7 0.007
East Asia 4.64 × 10-10 1.19 × 10-9
Americas 0.029 1.18 × 10-5 1.56 × 10-5 0.136
Oceania 1.17 × 10-8 0.002
P-values significant at <0.05 are shown in bold.
°N = degrees of latitude north of the equator.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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thirds of this cohort was heterozygous for the 5CGG and
4TGG haplotypes, and just over a fifth were heterozygous
for the 5CGG and 6CGG haplotypes (Table 8). Three
other haplotypes were found to be homozygous in indi-
viduals in this cohort but at a very low frequency; 4TGG,
6CGG, and 3CGG (Table 8).
Prostate Cancer
The DG8S737 -1 allele and the A allele of rs1447295 were
reported by Amundadottir et al. to be in strong linkage
disequilibrium (LD) within the Icelandic population (D'
= 0.85; r2 = 0.52), the HapMap Caucasian American (D' =
0.72; r2 = 0.29) and African (D' = 0.62; r2 = 0.21) popula-
tions, and African Americans (D' = 0.48; r2 = 0.12) [58].
Interestingly, haplotype analysis between the DG8S737
microsatellite and the rs1447295 SNP in this Indian
cohort found that whilst the -1 microsatellite allele was in
complete LD with the A-allele of rs1447295, the alleles
were weakly correlated (Table 10). Rather, it was the rarer
-4 allele (19 repeats) of DG8S737 that exhibited the great-
est correlation with the A-allele of rs1447295 (Table 10).
In this Indian cohort, the haplotype containing the minor
A-allele of the rs1447295 SNP and the -4 allele of
DG8S737 was found to represent 7.1% of the haplotypes
(Table 11). A further 1.4% carried the -4 allele of
DG8S737 but the major C-allele of rs1447295, and 5.8%
carried the minor A-allele of rs1447295 but a DG8S737
allele other than -4 (Table 11). The remaining 85.7% of
haplotypes were found to contain the major C-allele of
rs1447295 and a DG8S737 allele other than -4 (Table 11),
which resulted in 73.4% of this Indian cohort being
homozygous for these haplotypes (Table 12). We also
found that 1.2% of this cohort was homozygous for the
haplotype containing the -4 allele of DG8S737 and the
minor A-allele of rs1448295, and a further 11.8% were
heterozygous for this haplotype (Table 12). Of the latter
11.8%, a sixth had a second haplotype that contained the
-4 allele of DG8S737 but not the minor A-allele of
rs1448295, and just over half had a haplotype that con-
tained the minor A-allele of rs1448295 but not the -4
allele of DG8S737. Interestingly, there were no haplo-
types containing the -1 allele of DG8S737 and the minor
A-allele of rs1447295, with the -1 allele found always
associated with the C-allele of rs1447295. However, 6.6%
of the individuals carried a single copy of both the -1 allele
and the A-allele (data not shown).
Ability to taste PTC
The ability to taste PTC has been previously associated
with the haplotypes formed by three SNPs in the TAS2R38
gene; g.144C>G, g.784C>T, and g.885G>A [59]. Haplo-
type analysis of these three SNPs found that the haplotype
associated with an inability to taste PTC [59,60] was
almost twice as prevalent in this Indian cohort (AVI) than
the taster haplotype (PAV), with recombinants between
these two haplotypes being extremely rare by comparison
(Table 13). Almost half of the Indian cohort was found to
be heterozygous for the taster/non-taster haplotypes AVI/
PAV (Table 14). The most common homozygous haplo-
type was that of the non-taster AVI/AVI, which occurred
almost four times as frequently as homozygosity for the
taster haplotype PAV/PAV. Only 4.2% of the cohort pos-
sessed one of the taster or non-taster haplotypes and one
of the recombinant haplotypes (Table 14). No individuals
were found to possess only recombinant haplotypes.
As observed above, the Kashmiri group had the highest
MAFs for all three TAS2R38 SNPs and the Kannada group
had the lowest (Table 4). Based on their relative frequen-
cies, the Kashmiri would therefore be expected to have
twice the number of tasters as the Kannada. The Kashmiri
are one of the most northerly groups and the Kannada one
of the most southerly (Figure 1), suggesting a possible lat-
itudinal cline for the ability to taste PTC, with the greatest
number of tasters in the northern groups and the least in
the southern groups. This is supported by the MAF of the
three SNPs in the other Indian language groups (Figure 3;
Table 15). However, only the TAS2R38 g.144G>C SNP
follows the same trend in both the Indian groups and in
the other available world populations (Figure 3A; see
Additional file 1, Table S18). For both the TAS2R38
g.784C>T and g.885A>G, the trend observed with the
other world populations is the opposite of that observed
with the Indian language groups (Figures 3B &3C, respec-
tively; see Additional file 1, Tables S19 & S20, respec-
tively). For example, the Indian groups display a decrease
in MAF as the distance from the equator decreases,
whereas other world populations demonstrate an increase
in MAF as the distance from the equator decreases. The
correlation between frequency and latitude was found to
be the strongest for the TAS2R38 g.144G>C SNP, both
when the Indian groups and the other world populations
were considered separately and when they were combined
(Table 15; Figure 3A &3B). The correlation was weakest
for the TAS2R38 g.885A>G SNP, where it was still appre-
ciable for the Indian groups, but less so for the other
world populations (Table 15; Figure 3C).
Discussion
We have reported here the frequencies of common poly-
morphisms associated with an increased risk of several
diseases or phenotypes, within a cohort of 576 Indian-
born Asian Indians. It is important to note that because
the study participants were born in India, we refer to the
individuals and populations as being "Asian Indian" or
"Indian"; however, it is important to note that because the
Asian Indian individuals were sampled in the United
States, and therefore do not represent a random sample
from India or all of the different castes, tribes, or languageB
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Table 3: Allele frequencies of the polymorphisms associated with prostate cancer.
Prostate Cancer
Polymorphism: DG8S737 rs1447295
Nucleotide Change: MS C>A
n - 1 0 - 9- 8- 7- 6- 5- 4- 3- 2- 10+ 1 + 2 + 3 + 4 + 5 + 6 + 7 A
Mother Tongue
Assamese 26 0.000 0.040 0.000 0.000 0.000 0.020 0.120 0.020 0.060 0.180 0.220 0.100 0.060 0.080 0.080 0.020 0.000 0.000 0.120
Bengali 27 0.017 0.000 0.000 0.000 0.000 0.000 0.034 0.121 0.155 0.190 0.103 0.155 0.052 0.121 0.052 0.000 0.000 0.000 0.121
Gujarati 181 0.000 0.042 0.000 0.000 0.042 0.000 0.021 0.042 0.229 0.188 0.188 0.042 0.042 0.125 0.042 0.000 0.000 0.000 0.125
Hindi 29 0.023 0.023 0.000 0.012 0.012 0.012 0.128 0.035 0.151 0.209 0.116 0.093 0.035 0.070 0.023 0.035 0.023 0.000 0.186
Kannada 24 0.000 0.071 0.000 0.000 0.018 0.000 0.089 0.036 0.161 0.268 0.125 0.036 0.000 0.143 0.054 0.000 0.000 0.000 0.125
Kashmiri 24 0.000 0.000 0.000 0.000 0.000 0.000 0.060 0.060 0.120 0.220 0.120 0.200 0.040 0.120 0.060 0.000 0.000 0.000 0.040
Konkani 43 0.000 0.019 0.000 0.000 0.019 0.019 0.077 0.115 0.135 0.173 0.192 0.058 0.135 0.019 0.019 0.019 0.000 0.000 0.192
Malayalam 25 0.000 0.000 0.000 0.000 0.000 0.000 0.093 0.037 0.167 0.204 0.111 0.185 0.019 0.148 0.000 0.019 0.000 0.019 0.074
Marathi 26 0.000 0.000 0.000 0.000 0.037 0.000 0.074 0.037 0.093 0.278 0.111 0.130 0.056 0.093 0.056 0.037 0.000 0.000 0.111
Marwari 25 0.000 0.008 0.003 0.000 0.008 0.022 0.110 0.028 0.116 0.293 0.122 0.077 0.058 0.105 0.041 0.006 0.003 0.000 0.141
Oriya 27 0.000 0.000 0.019 0.019 0.058 0.038 0.058 0.135 0.077 0.173 0.173 0.096 0.038 0.077 0.019 0.019 0.000 0.000 0.308
Parsi 25 0.000 0.000 0.020 0.000 0.040 0.000 0.020 0.020 0.380 0.220 0.100 0.140 0.020 0.020 0.020 0.000 0.000 0.000 0.040
Punjabi 28 0.000 0.000 0.000 0.000 0.017 0.000 0.052 0.069 0.121 0.345 0.121 0.086 0.086 0.069 0.034 0.000 0.000 0.000 0.034
Tamil 29 0.000 0.000 0.000 0.000 0.018 0.018 0.161 0.018 0.125 0.143 0.143 0.143 0.054 0.107 0.054 0.018 0.000 0.000 0.161
Telugu 28 0.000 0.021 0.000 0.000 0.000 0.000 0.042 0.104 0.188 0.375 0.083 0.021 0.042 0.042 0.021 0.042 0.000 0.021 0.104
FST 0.007 0.020
p-value 11
Gender
Female 237 0.002 0.021 0.004 0.002 0.019 0.011 0.078 0.044 0.146 0.251 0.129 0.099 0.057 0.078 0.049 0.011 0.000 0.000 0.120
Male 339 0.003 0.009 0.001 0.001 0.013 0.013 0.091 0.052 0.140 0.242 0.133 0.094 0.049 0.105 0.032 0.013 0.004 0.003 0.136
FST 00
p-value 11
Population
Cohort 576 0.003 0.014 0.003 0.002 0.016 0.012 0.085 0.050 0.142 0.245 0.130 0.098 0.052 0.094 0.039 0.012 0.003 0.002 0.129
Standard 
Error
0.002 0.006 0.002 0.001 0.005 0.003 0.011 0.010 0.020 0.017 0.010 0.014 0.008 0.010 0.005 0.004 0.002 0.002 0.018
HWE 
Constant
0.003 0.002
p-value 0.433 0.580
Welch 
modified t-
test:
Africa
Europe 0.091
Asia 0.486
Americas
Alleles of DG8S737 were assigned based upon the change in the number of repeats away from that of the reference sequence in the NCBI database (23 AC dinucleotide repeats). Allele 
-1 is equivalent to the prostate cancer risk-associated -8 allele reported by Amundadottir et al. that had 22 repeats [58]. P-values significant at <0.05 are shown in bold.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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groups, some biases may be introduced when extrapolat-
ing the results to India as a whole [10]. It is also important
to note that because Hindi is spoken by 43 percent of the
Indian population, primarily in the states of Northern
India, heterogeneity will be present between its various
constituent population groups. Our Hindi language
group is a sample of individuals who emigrated from a
restricted region of India, and therefore biases may be
introduced when extrapolating their results to Hindi
speakers as a whole.
All polymorphisms, with the exception of ALOX5
g.20C>T, were found to be in HWE. The deviation away
from HWE for the ALOX5 g.20C>T SNP is most likely due
to chance, but given its low frequency we cannot exclude
the possibility of genetic drift, differing selection between
the groups, or the small sample size of all but one
Table 4: Allele frequencies of the polymorphisms associated with melanogenesis, Hirschsprung disease, AMD, and the ability to taste 
PTC.
Melanogenesis Hirschsprung AMD Ability to Taste PTC
Gene Name: SLC24A5 RET CFH LOC387715 TAS2R38 TAS2R38 TAS2R38
Nucleotide Change: g.13242G>A g.9349G>A g.37989T>C g.205G>T g.144G>C g.784C>T g.885A>G
n GT C T C C G
Mother Tongue
Assamese 26 0.260 0.240 0.360 0.200 0.340 0.360 0.360
Bengali 27 0.293 0.207 0.276 0.397 0.310 0.310 0.310
Gujarati 181 0.208 0.271 0.333 0.375 0.313 0.313 0.313
Hindi 29 0.105 0.209 0.267 0.244 0.349 0.360 0.360
Kannada 24 0.268 0.232 0.304 0.464 0.196 0.250 0.250
Kashmiri 24 0.020 0.100 0.260 0.340 0.480 0.500 0.500
Konkani 43 0.058 0.250 0.385 0.269 0.308 0.308 0.308
Malayalam 25 0.259 0.259 0.222 0.500 0.259 0.296 0.296
Marathi 26 0.296 0.259 0.278 0.204 0.407 0.407 0.426
Marwari 25 0.041 0.273 0.265 0.334 0.384 0.398 0.406
Oriya 27 0.154 0.346 0.212 0.250 0.346 0.365 0.365
Parsi 25 0.100 0.300 0.300 0.380 0.280 0.280 0.300
Punjabi 28 0.052 0.293 0.431 0.414 0.328 0.310 0.328
Tamil 29 0.036 0.179 0.250 0.393 0.339 0.321 0.375
Telugu 28 0.000 0.188 0.167 0.354 0.417 0.417 0.417
FST 0 0.011 0.009 0 0.009 0.010 0.011
p-value 1 1 1 1 1 1 1
Gender
Female 237 0.110 0.232 0.268 0.348 0.331 0.338 0.342
Male 339 0.117 0.261 0.289 0.330 0.363 0.376 0.386
FST 0.049 0.020 0.037 0.042 0.020 0.007 0
p-value 0.825 0.887 0.847 0.837 0.887 0.933 1
Population
Cohort 576 0.114 0.249 0.280 0.338 0.350 0.360 0.368
Standard Error 0.028 0.015 0.018 0.024 0.018 0.017 0.017
HWE Constant 0.004 0.003 0.009 0.006 0.002 0.002 0.002
p-value 0.304 0.654 0.350 0.513 0.926 0.855 0.857
Welch modified t-test:
Africa 4.21 × 10-14 3.86 × 10-4 3.24 × 10-8 0.005
Europe 2.80 × 10-4 4.20 × 10-3 0.068 2.43 × 10-6 5.78 × 10-5 1.37 × 10-4
Asia 7.18 × 10-14 1.55 × 10-8 0.018 0.055 7.97 × 10-6 7.60 × 10-6
Americas 0.024 0.006 1.92 × 10-5 1.64 × 10-5
Oceania 0.090 0.009 0.003
P-values significant at <0.05 are shown in bold.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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(Gujarati) of our language groups. Genotyping error
could be another possible explanation, but the extremely
high accuracy of the TaqMan genotyping assay [61] and
the 100% concordance of replicated genotypes makes this
explanation unlikely.
No significant population subdivision was identified by
FST between the different Indian language groups (Tables
2, 3, &4). However, variation in the MAF of some of the
polymorphisms between the different language groups
was observed. Furthermore, the ALOX5 g.8322G>A and
g.50778G>A SNPs, as well as the PTPN22 g.36677C>T
SNP, were found to be present in some but not all of the
Indian language groups investigated here. There was no
discernible pattern to presence/absence of the minor
allele of these SNPs with regard to the location of these
groups within India (Figure 1), and it is possible that their
presence or absence is the result of either the different ori-
gins of the language groups during the peopling of India
and strengthened by their practice of endogamy [62,63],
or admixture introduced by the differential migration of
non-Indian populations into regions of India during the
course of its history [64,65]. With the exception of the
Gujaratis, the small sample size of our individual lan-
guage groups could also be responsible for this observa-
tion as we may be under powered to detect the minor
allele in these groups. However, the absence of the ALOX5
g.8322G>A,  ALOX5  g.50778G>A, and PTPN22
g.36677C>T SNPs in the Gujarati language group, for
which we have around seven times the number of individ-
uals of the other groups, would suggest that their absence
in the other groups may not necessarily be due to a lack of
a sufficient sample size for their detection. If this observed
variation in the MAF of some of the polymorphisms
between the different language groups is confirmed, then
this could impact the design of future case-control studies
in India as it would suggest that the inclusion of a dispro-
portionate number of individuals from a particular lan-
guage group in either the case or control groups could lead
to missed or spurious associations.
Interestingly, the MAF of the atherosclerosis (ALOX5P,
ALOX5 g.20C>T, g.8322G>A, and g.50778G>A), type-1
and type-2 diabetes (CAPN10  g.4834T>C,  TCF7L2
g.98386G>T, and PTPN22  g.36677C>T), and Hirschs-
prung disease (RET  g.9349G>A) associated polymor-
phisms were found to be similar to those of European
populations. Similarly, the frequencies of variants associ-
ated with AMD (CFH  g.37989T>C and LOC388715
g.205G>T) and prostate cancer (DG8S737 and rs1447295
were similar to those of African populations. However,
none showed a high similarity to the populations of East-
ern Asia. This could reflect a greater degree of non-Asian
compared to Asian gene flow into India during the course
of its history; however, if higher caste is correlated with a
The correlation between minor allele frequency and latitude  of (A) CYP3A5 g.6980G>A, (B) AGT g.802C>T, and (C)  GNB3 g.4423C>T Figure 2
The correlation between minor allele frequency and latitude 
of (A) CYP3A5 g.6980G>A, (B) AGT g.802C>T, and (C) 
GNB3 g.4423C>T. Correlation coefficients for each graph 
can be found in Table 5.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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European or western Asian component of ancestry, this
could be a reflection of our sampling of Asian Indian
immigrants in the United States that are likely biased
towards the higher castes.
The frequency of the CYP3A5 g.6980G>A, AGT g.802C>T,
and GNB3 g.825C>T polymorphisms have been reported
to vary significantly between different populations/eth-
nicities in a cline that correlates with variation in the lati-
tudinal position of the populations [50,55,56]. We have
shown that whilst the MAF of the CYP3A5 g.6980G>A
SNP in the Indian groups agrees with the trend identified
in other world populations, the inclusion of the Indian
data reduces the previously reported correlation between
the frequency of the AGT g.802C>T and GNB3 g.4423C>T
SNPs and latitude. The association of the MAF of these
three SNPs with changes in latitude, purportedly due to
their effects on sodium homeostasis, suggests that the rel-
evant selective pressures within India are not themselves
strongly correlated with latitude.
An association between changes away from the common
allele (5 repeats) in a repeat-polymorphism (ALOX5P)
comprised of Sp1 binding sites in the promoter region of
ALOX5 and atherosclerosis has been previously reported
[57]. Analysis of ALOX5P in the Indian cohort identified
six alleles; 56.4% of individuals were homozygous for the
common allele of five Sp1-binding site repeats, and
92.5% of individuals had at least one copy of the com-
mon allele. The remaining 7.5% of individuals had two
variant alleles, which is much lower than the incidence of
CAD in the Indian population [16,66]. This is higher than
the 5.96% reported for a cohort of individuals of mixed-
ethnicity, who reported 94.0% of individuals with at least
one copy of the common allele [57]. The same study also
reported that variant alleles were more common in blacks
(24.0%) and Asians or Pacific Islanders (19.4%) than in
Hispanic (3.6%) and non-Hispanic whites (3.1%). The
Table 7: Frequencies of the identified ALOX5 polymorphism 
haplotypes.
Haplotype Frequency
5CGG 0.726
4TGG 0.179
6CGG 0.046
5CAG 0.017
4CGG 0.012
6TGG 0.010
3CGG 0.003
3CGA 0.003
5CGA 0.002
3TGG 0.001
5TGG 0.001
7CGG 0.001
8CGG 0.001
Polymorphisms are ordered 
ALOX5P→g.20C>T→g.8322G>A→g.50778G>A. Haplotypes 
containing common ALOX5P 5-repeat allele are shown in bold.
Table 6: Squared correlation (r2) values between alleles of 
ALOX5P and the three coding ALOX5 SNPs.
Allele g.20C>T g.8322G>A g.50778G>A
3 8.79 × 10-5 9.87 × 10-5 0.253 [G]
4 0.949 [T] 0.004 1.89 × 10-5
5 0.674 [C] 0.006 0.013
6 0.014 0.001 2.67 × 10-4
7 2.07 × 10-4 1.43 × 10-5 3.94 × 10-6
8 2.07 × 10-4 1.43 × 10-5 3.94 × 10-6
Significant r2 values are shown in bold.
Table 5: Correlation coefficients of hypertension-associated polymorphism MAFs with latitude.
Polymorphism Population Adjusted Spearman Rank 
Correlation Score
Adjusted r2
CYP3A5 g.6980G>A CEPH-HGDP -0.621** 0.319
CEPH-HGDP + HapMap -0.620** 0.349
CEPH-HGDP + HapMap + AIP -0.603** 0.302
AGT g.802C>T CEPH-HGDP -0.718** 0.409
CEPH-HGDP + Others -0.693** 0.373
CEPH-HGDP + Others + AIP -0.518** 0.248
GNB3 g.825C>T Others -0.620** 0.278
Others + AIP -0.300* 0.101
* significant at 0.05, ** significant at 0.01
CEPH-HGDP = Centre d'Etude du Polymorphisme Humain-Human Genome Diversity Panel.
AIP = Asian Indian population.
Others = data from other populations that were not part of CEPH-HGDP or HapMap.
For sample sizes, please see Additional file 1, Tables S4, S5, S6, for CYP3A5 g.6980G>A, AGT g.802C>T, and GNB3 g.825C>T, respectively.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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frequency of variants in this Indian cohort would suggest
that their frequency is closer to Caucasians than Asians.
Three coding SNPs have also been identified in the ALOX5
gene (g.20C>T, g.8322G>A, and g.50778G>A) and these
appear to be in partial or complete LD with the alleles of
ALOX5P (HA; unpublished data). Haplotype analysis of
the four ALOX5  polymorphisms in this Indian cohort
found that there is LD between three alleles of ALOX5P –
the major and minor alleles of the g.20C>T SNP (5 and 4
repeats, respectively), and the major allele of g.50778G>A
SNP (3 repeats). Haplotypes containing variant alleles of
ALOX5P are present in almost half of the cohort, with
8.1% of the cohort homozygous for haplotypes carrying a
variant allele.
Analysis of the type-2 diabetes-associated SNPs CAPN10
g.4834T>C and TCF7L2 g.98386G>T, found their MAFs
(23.1% and 24.8%, respectively) to be almost twice as
common as type-2 diabetes in the Indian population
(11.6%) [22]. Two recent studies have reported that the
TCF7L2 g.98386G>T variant is strongly associated with
type-2 diabetes risk in a Asian Indians [67,68], and our
frequency of this variant (24.8%) in this Indian cohort is
close to that reported for control subjects (22%) [68]. The
PTPN22 g.36677C>T SNP has a low MAF (0.009) in our
Indian cohort, comparable to that previously reported
(0.012) [69] and almost one hundred fold higher than the
reported prevalence of type-1 diabetes in the Indian pop-
ulation (0.011–0.026%) [30,31]. The minor allele of
PTPN22 g.36677C>T SNP is absent in other Asian popu-
lations, but present in those of European origin (see Addi-
tional file 1, Table S9), suggesting that its presence in
Asian Indians is through the introduction of admixture by
migrating individuals of European origin into India dur-
ing the course of its history.
Table 11: Haplotype frequencies for the -4 allele of the DG8S737 
microsatellite and the alleles of rs1447295.
Haplotype Frequency
-4/C 0.014
-4/A 0.071
*/C 0.857
*/A 0.058
* denotes all other DG8S737 alleles.
Table 9: Frequencies of the ALOX5 diplotypes containing the 
common 5-repeat allele of ALOX5P.
Diplotype Frequency
5CGG/5CGG 0.531
5CGG/5* 0.033
5CGG/* 0.356
5*/* 0.005
*/* 0.075
* indicates all other haplotypes.
Table 8: Frequencies of the identified ALOX5 polymorphism 
diplotypes.
Diplotype Frequency
5CGG/5CGG 0.531
4TGG/5CGG 0.253
5CGG/6CGG 0.086
4TGG/4TGG 0.051
5CGG/5CAG 0.031
4CGG/6TGG 0.016
3CGA/5CGG 0.005
6CGG/6CGG 0.003
4CGG/5CGG 0.003
4CGG/5CGA 0.003
5CGG/6TGG 0.003
3CGG/3CGG 0.002
3CGG/5CGG 0.002
3TGG/4TGG 0.002
4CGG/4TGG 0.002
4TGG/5CAG 0.002
5CGG/7CGG 0.002
5CGG/8CGG 0.002
5CGG/5TGG 0.002
Polymorphisms are ordered 
ALOX5P→g.20C>T→g.8322G>A→g.50778G>A.
Haplotype containing the common allele for all polymorphisms is 
shown in bold.
Haplotypes containing the common ALOX5P 5-repeat allele but not 
the common allele of all three SNPs are underlined.
Table 10: Linkage disequilibrium (D') and the squared 
correlation (r2) values between alleles of DG8S737 and 
rs1447295.
Allele D' r2
-10 0.551 0.005
-9 1.000 0.002
-8 1.000 3.88 × 10-4
-7 0.326 0.001
-6 0.160 0.002
-5 0.812 0.055
-4 0.802 0.403 [A]
-3 0.345 0.043
-2 0.417 0.004
-1 1.000 0.048
0 1.000 0.022
1 0.972 0.015
2 1.000 0.008
3 0.866 0.012
4 1.000 0.006
5 1.000 0.002
6 0.551 0.005
7 0.326 0.001
Allele -1 is equivalent to the prostate cancer risk-associated -8 allele 
reported by Amundadottir et al. that had 22 repeats [58].BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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Interestingly, the most common allele of the DG8S737
microsatellite in this Indian cohort has been associated
with an increased risk of prostate cancer in other popula-
tions (-1 allele) [58]. However, whilst this allele has been
reported to be in strong LD with the minor A-allele of SNP
rs1447295 in other populations, we have found that a dif-
ferent allele (-4 allele) is in strong LD with the minor A-
allele of SNP rs1447295 in this Indian cohort. The fre-
quency of these polymorphisms is also still far higher
than the frequency of prostate cancer in the Asian Indian
population (10 per 100,000) [28,29]. Further studies on
Asian Indian prostate cancer cases may allow for the true
causative variant to be identified.
The moderate frequency of the Hirschsprung disease-asso-
ciated minor allele of RET  g.9349G>A in the Indian
cohort is in contrast with the relatively low frequency of
the disease in India (2.8 per 10,000 births) [25]. However,
the MAF of the CFH  g.37989T>C and LOC387715
g.205G>T SNPs in this Indian cohort is in agreement with
the low frequency of AMD in the Indian population [27].
Previous investigation suggests that the PAV "taster" hap-
lotype is dominant over the other recessive haplotypes
including the "non-taster" AVI haplotype as PAV/AVI
individuals were largely able to taste PTC [59,70]. We
would therefore expect, based upon the frequencies of the
different haplotypes in this Indian cohort, that 57.4% of
the population would be able to taste PTC (Table 16).
This value is very close to the percentage of the population
identified as able to taste PTC in previously reported stud-
ies: Gujarat (57.1%), Kerala (51.6%), Maharashtra
(54.9%, 57.6% and 63.7%), Tamil Nadu (59.2%), and
Uttar Pradesh (69.1%) [71-75]. These data would suggest
that the lower than expected number of Indians able to
taste PTC when compared with the average of 75% in
worldwide populations [76,77] is due to an increased
presence of the non-taster haplotype in this population.
In agreement with this notion, we observed that the fre-
quency of the haplotype of the three SNPs in the TAS2R38
gene associated with the ability to taste PTC in this Indian
cohort is almost 20% lower than other world popula-
tions.
Interestingly, the MAFs of the three TAS2R38 SNPs were
found to vary in the Indian groups in a cline that corre-
lated with the latitudinal variation of the groups. The
MAFs of all three SNPs were higher in the more northerly
Indian groups than in the more southerly groups, suggest-
ing a greater frequency of tasters in the former than the lat-
ter. However, this trend was only observed in the other
world populations for the TAS2R38 g.144G>C SNP, with
the trend reversed for both the TAS2R38 g.784C>T and
g.885A>G SNPs.
One possible explanation for the differences between the
trends in the Indian groups and other world populations
could be the differential migration of non-Indian individ-
uals into different parts of India during the course of its
history. This could result in variation in the degree and
source of the admixture introduced into the different lan-
guage groups such that their frequencies deviate from the
Table 14: Individual diplotypes of the identified TAS2R38 
polymorphisms and their corresponding frequencies in the Asian 
Indian cohort.
Diplotype
Genotype Prototype Frequency
GTA/CCG AVI/PAV 0.437
GTA/GTA AVI/AVI 0.402
CCG/CCG PAV/PAV 0.120
GCG/GTA AAV/AVI 0.017
GTG/CCG AVV/PAV 0.009
GCG/CCG AAV/PAV 0.007
CTG/GTA PVV/AVI 0.005
CCG/GTG PAV/AVV 0.002
GTA/GCG AVI/AAV 0.002
Polymorphisms ordered as g.144C>G, g.784C>T, and g.885G>A
Taster haplotype is shown in bold (PAV), and the non-taster 
haplotype is shown underlined (AVI).
Table 12: Diplotype frequencies for the -4 allele of the DG8S737 
microsatellite and the alleles of rs1447295.
Diplotype Frequency
(*/C)/(*/C) 0.734
(*/C)/(*/A) 0.109
(*/C)/(-4/C) 0.026
(*/C)/(-4/A) 0.109
(*/A)/(-4/A) 0.007
(-4/C)/(-4/A) 0.002
(-4/A)/(-4/A) 0.012
* denotes all other DG8S737 alleles.
Table 13: TAS2R38 haplotypes, their corresponding prototypes, 
and frequencies in the Asian Indian cohort.
Haplotype
Genotype Prototype Frequency
GTA AVI 0.630
CCG PAV 0.345
GCG AAV 0.014
GTG AVV 0.006
CTG PVV 0.003
CCA PAI 0.001
Polymorphisms ordered as g.144C>G, g.784C>T, and g.885G>A
Taster amino acid haplotype (prototype) is shown in bold (PAV), and 
the non-taster haplotype is shown underlined (AVI).BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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trends of other populations. There could also be selective
pressures that are unique to, more important in, or differ-
ent in action in, India than the other world populations,
and that also share a strong correlation with latitude.
It has been previously reported that balancing selection is
acting on the TAS2R38 receptor gene, possibly due to the
different taster and non-taster alleles encoding receptors
that recognize different, but equally important, ligands
[60,77]. The latitudinal cline we have identified in our
Indian language groups with regards to the taster/non-
taster allele frequencies could therefore be the result of the
strength of the selective pressures exerted by these ligands
affecting individuals in the north and south of India dif-
ferently, but for reasons that are distinct from other world
populations. Another possible selective pressure relates to
bitter taste perception and the acceptance of foods con-
taining increasing amounts of spice [78]. This is of partic-
ular interest given that patterns of spice use have been
reported to both vary between populations and regions,
and also to have a significant latitude correlation, where
more spices tend to be used in warmer climates purport-
edly due to their powerful antimicrobial action [79]. The
climate differences between the more arid south of India
and the more mountainous north, and the incorporation
of a lot of spices in Indian cooking, makes this a possible
explanation for our latitudinal correlation. It has also
been proposed that the local adaptation in human bitter
taste receptor genes is common and has been driven by
the fitness advantages of avoiding toxic, bitter compounds
found in plants [80]. If the composition and abundance
of ligands to which the different taster and non-taster alle-
les of the TAS2R38 gene vary geographically in India in a
cline associated with latitude, this could also explain our
observed latitudinal correlation.
The MAF for the SLC24A5 g.13242G>A polymorphism
(0.114) in the Indian population is closer to that of Cau-
casian European populations (0.000–0.020) than to that
of East Asians (0.979–0.989) and Africans (0.730–0.980)
(see Additional file 1, Table S14). This is surprising given
that, as a whole, people of Indian origin have darker skin
tone compared to Europeans. The East Asian and African
populations share a similarly high frequency of the minor
allele of the SLC24A5 g.13242G>A SNP, which in itself is
surprising as East Asians are typically of much lighter skin
than Africans. It is also interesting that the t-test suggested
a greater similarity in MAF between Indians and those of
populations in the Americas (Puerto Rican, Mexican, and
Amerindian), who are of a similar skin tone (Table 4). The
presence of the minor allele of the SLC24A5 g.13242G>A
SNP cannot therefore, completely explain Indian skin
color, making the investigation of polymorphisms in
additional genes implicated in skin pigmentation [81]
essential to understanding the intricacies of their skin
color.
We have found that, with the exception of the TAS2R38
haplotypes associated with the ability to taste PTC, the fre-
quency of the disease/trait-associated minor alleles of the
polymorphisms investigated in this Indian cohort did not
correlate with the reported disease/trait prevalence in the
Indian population. This is unsurprising given that, with
the exception of the ability to taste PTC, all are known to
be complex diseases/traits that are the result of the com-
bined effect of variants at multiple genetic loci and envi-
ronmental factors. Variation in genetic backgrounds and
environmental heterogeneity between populations will
likely have a modifying effect on the correlation of the
allele frequency of polymorphisms with disease/trait
prevalence as their contribution to the presentation of the
disease/trait varies. The degree of complexity between
these disease/traits will also vary, as some, such as CAD,
are known to be highly complex whereas others, such as
AMD, may be less complex. One might therefore not
expect the correlation of factors associated with CAD to be
Table 15: Correlation coefficients of the MAFs of the three TAS2R38 SNPs with latitude.
Polymorphism Population Adjusted Spearman Rank 
Correlation Score
Adjusted r2
g.144G>C AIP 0.535* 0.186
Others 0.386* 0.126
Others + AIP 0.369** 0.154
g.784C>T AIP 0.474 0.180
Others -0.670** 0.429
Others + AIP -0.305* 0.085
g.885A>G AIP 0.433 0.118
Others -0.241 0.055
Others + AIP 0.063 -0.017
* significant at 0.05, ** significant at 0.01
AIP = Asian Indian population
Others = data from non-Asian Indian populations
For sample sizes, please see Additional file 1, Tables S18, S19, §20, for g.144G>C, g.784C>T, and g.885A>G, respectively.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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as strong as those associated with AMD, and therefore the
lack of a strong correlation between many of these poly-
morphisms and their respective complex disease/trait
prevalence most likely indicates that the environmental
and/or other genetic factors make a stronger contribution
to the presentation of the disease/trait in Indians than do
these variants alone. Interestingly, the two polymor-
phisms associated with AMD (CFH  g.37989T>C
&LOC387715 g.205G>T), whilst not showing strong cor-
relation between their disease-associated MAF and
reported disease prevalence in the Indian population, did
show a frequency that correlated with the MAF of these
SNPs in other populations and the prevalence of AMD in
those populations, suggesting that they may share similar
risk factors.
Conclusion
The Asian Indian population represents a large popula-
tion within which many complex-trait disorders are found
at a high frequency. The high prevalence of endogamy and
relatively low admixture present in this population distin-
guishes it from most other populations presently used in
genetic studies as it represents a distinct genetic back-
ground that is largely unaffected by outside admixture. In
some cases, such as coronary artery disease, Asian Indians
exhibit unique phenotypic characteristics that distinguish
them from the other populations, suggesting that unique
causative factors underlie this and possibly other related
diseases. Our results suggest that caution should be used
when treating the Asian Indian population as a single
population in genetic studies using SNPs. The overall dif-
ference in minor allele frequency of the polymorphisms
investigated was small between the different language
groups, but some inter-group variation was observed.
However, caution is warranted in interpreting our results
as whilst our Indian cohort is likely to be reasonably rep-
resentative of first-generation individuals of Asian Indian
descent currently residing in the United States, individuals
from relatively mobile populations and those of higher
caste and socioeconomic status are likely overrepresented
within this cohort. Such individuals likely do not provide
a random sample of the source populations in India and
therefore if variables such as caste and socioeconomic sta-
tus do have a significant effect on genotype frequency in
India, this will not be reflected in these results. Addition-
ally, if higher caste is correlated with a European or west-
ern Asian component of ancestry, a sample in the United
States may be biased towards finding a greater similarity
of populations from India to those of the Europe/Middle
East rather than to those of East Asia [10], as we have dis-
covered for many of the polymorphisms reported here.
We must also use caution when interpreting the variation
at the PTPN22 g.1825C>T and ALOX5 g.50778G>A loci
between the 15 language groups, as the small sample size
for each group, with the exception of the Gujarati, is a lim-
The correlation between latitude and minor allele frequency  of the TAS2R38 SNPs (A) g.144G>C, (B) g.784C>T, and (C)  g.885A>G Figure 3
The correlation between latitude and minor allele frequency 
of the TAS2R38 SNPs (A) g.144G>C, (B) g.784C>T, and (C) 
g.885A>G. Correlation coefficients for each graph can be 
found in Table 15.BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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iting factor in our ability to detect polymorphisms with a
low minor allele frequency. However, our results do sup-
port the inclusion of the Indian population in modern
genetic association studies as these data suggest that Asian
Indians likely exhibit unique genotype as well as pheno-
type characteristics that may yield new insight into the
underlying causes of diseases that are not available in
other populations.
Methods
Study population
The Asian Indian cohort used in this study was as previ-
ously described [10]. Our sample consisted of an
expanded population of 576 individuals of Indian-born
Asian Indians living in the United States who have largely
emigrated from Indian cities. This population was
designed so that when subdividing study participants by
their self-reported primary spoken Indian language, 15
languages (Assamese, Bengali, Gujarati, Hindi, Kannada,
Kashmiri, Konkani, Malayalam, Marathi, Marwari, Oriya,
Parsi, Punjabi, Tamil, and Telugu), each having a rela-
tively localized distribution within India (Figure 1),
would be well-represented. The number of Gujarati indi-
viduals sampled (181) was larger than the other language
groups (ca. 25–30) to examine rare minor allele frequen-
cies. Three other language groups (Dogri, Sindhi, and
Tulu) were present in the population but not at a signifi-
cant number to be analyzed independently, but these
were retained for whole cohort analysis. A sample size of
at least 24 per population has been found to be reasona-
bly suitable for population structure analysis [82,83], as
well as for microsatellite studies of linkage disequilibrium
[84], suggesting that it is suitable for this study.
Marker genotyping
All single nucleotide polymorphisms (SNPs) were interro-
gated using TaqMan allelic discrimination assays (Applied
Biosystems, Foster City, CA) following the manufacturer's
recommended protocol for a 5 µl reaction volume and
2ng of dried DNA using an Applied Biosystems (Foster
City, CA) 7900HT fast real-time PCR system. ABgene
(Rochester, New York) ABsolute™ QPCR ROX (500 nM)
mix was used for all assays. Pre-designed assays were avail-
able for all SNPs except CFH  g.37989T>C (Probe: 5'-
TTTCTTCCAT [G/A]ATTTTG-3'; Forward primer: 5'-
CTTTATTTATTTATCATTGTTATGGTCCTTAGGAAAATGT-
TATTT-3'; Reverse primer: 5'-GGCAGGCAACGTCTATA-
GATTTACC-3'),  ALOX5  g.20C>T (Probe: 5'-TGGCCAC
[G/A]GTGACC-3'; Forward primer: 5'-CGCCATGCCCTC-
CTACAC-3'; Reverse primer: 5'-AGTGCCGGCGAACCA-
3'),  ALOX5  g.8322G>A (Probe: 5'-CTGAAGAC[G/
A]CCCCACG-3'; Forward primer: 5'-TGAATGACGACT-
GGTACCTGAAGTA-3'; Reverse primer: 5'-GGTGATC-
CAGCGGTAGCA-3'), and ALOX5 g.50778G>A (Probe: 5'-
CTGCCC [G/A]AGAAGC-3'; Forward primer: 5'-AGACCT-
GATGTTTGGCTACCAGTT-3'; Reverse primer: 5'-CGCTC-
CAGGCTGCACTCTA-3'), for which custom assays were
designed using the Applied Biosystems (Foster City, CA)
assay-by-design service. All genotypes were determined
using the AutoCall clustering algorithm of the Sequence
Detection Systems (SDS) software version 2.1 (Applied
Biosystems, Foster City, CA) with a quality value thresh-
old of 95. Genotypes that could not be called using this
algorithm and threshold were repeated along with a small
number of successfully genotyped samples to validate
their genotypes and confirm assay performance in the
repeated data. No switches in genotypes were observed
with these replicated samples.
Microsatellite markers were genotyped using fluorescent
primers on an ABI3100 genetic analyzer (Applied Biosys-
tems, Foster City, CA) and analyzed using Genotyper ver-
sion 3.7 (Applied Biosystems, Foster City, CA). Primers
for DG8S737 were as previously described [58] and PCR
was performed using a Biometra (Goettingen, Germany)
T-Gradient thermal cycler and the following cycle param-
eters: 95°C 5 mins followed by 35 cycles of 95°C for 45
sec, 60°C for 45 sec, 72°C for 45 sec, and a final hold at
72°C 10 mins before holding at 4°C. New England
Biolabs (Ipswich, MA) Taq DNA polymerase (1U) and
manufacturer supplied 10× buffer (including 1.5 mM
MgCl2) was used along with 4 pmol of each primer, 30
µmol of each dNTP (Invitrogen, Carlsbad, CA), and 30 ng
DNA in a 15 µl reaction volume. Alleles of DG8S737 were
Table 16: Frequencies of taster and non-taster associated diplotypes in the Asian Indian cohort.
Diplotype
Genotype Prototype Frequency
CCG/CCG PAV/PAV 0.120
CCG/* PAV/* 0.017
GTA/CCG AVI/PAV 0.437
GTA/* AVI/* 0.024
GTA/GTA AVI/AVI 0.402
Polymorphisms ordered as g.144C>G, g.784C>T, and g.885G>A
Taster haplotype is shown in bold (PAV), and the non-taster haplotype is shown underlined (AVI).BMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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assigned based upon the change in the number of repeats
away from that of the reference sequence in the NCBI
database (23 AC dinucleotide repeats; Acc. #
NT_008046.15: 148848–149016).
Primers for the ALOX5 promoter microsatellite (ALOX5P)
were as previously described [85] but with the inclusion of
the GTGTCTT pig-tail [86] and PCR was performed in an
Applied Biosystems (Foster City, CA) GeneAmp 9700
thermal cycler using the following cycle parameters: 95°C
12 mins followed by 10 cycles of 94°C for 1 min, 68°C
for 2 min, followed by 25 cycles of 94°C for 30 sec, 60°C
for 30 sec, 72°C for 45 sec, and a final hold at 72°C 5
mins before holding at 4°C. Applied Biosystems (Foster
City, CA) AmpliTaq Gold DNA polymerase (1.2U) and
manufacturer supplied 10× buffer was used along with 1.5
mM MgCl2, 2% DMSO, 400 nmol of each primer, 30
µmol of dATP, dUTP, and dCTP (Invitrogen, Carlsbad,
CA), 62.5 µmol 7-deaza-dGTP (New England Biolabs, Ips-
wich, MA), and 30 ng DNA in a 25 µl reaction volume.
Labels for the alleles of ALOX5P were assigned based
upon the number of hexanucleotide Sp1-binding sites
that were present.
Haplotype analysis
Haplotype phase was estimated for the TAS2R38
g.144G>C, g.784C>T, and g.885A>G SNPs using fast-
PHASE version 1.1.4 [87] using the following settings; 50
random starts of the EM algorithm, 50 iterations of the
EM algorithm, 200 haplotypes sampled from the "poste-
rior" distribution obtained from a particular random start
of the EM algorithm, and haplotype frequencies estimated
by Monte Carlo methods by sampling from the observed
genotypes 10,000 times per diploid individual. As fast-
PHASE is unable to analyze microsatellite data, PHASE
version 2.1 [88,89] was used to estimate haplotype phase
for the ALOX5P and the three coding SNPs (g.20C>T,
g.8322G>A, and g.50778G>A) and also for DG8S737 and
rs1447295 using the following settings; a burn-in of
25,000 iterations followed by 10,000 main iterations with
a thinning interval of 100 iterations. The final run used 10
times this number of burn-in and main iterations. Haplo-
types were constructed using the hybrid haplotype recon-
struction model that uses a model that ignores the decay
of LD with distance [88] for preliminary computations,
and a different model that makes explicit allowance for
the decay of LD with distance [90] for the final computa-
tions.
Statistical analysis
All statistics were calculated in R version 2.3.1 [91] unless
otherwise stated. To test that all SNPs are in equilibrium
within the Asian Indian cohort, a Hardy-Weinberg equi-
librium (HWE) constant was calculated for each polymor-
phism using the HWE.test  function in the genetics  R-
package [92]. A Pearson's χ2 test with simulated p-value
(based on 10000 iterations) was calculated for all HWE
statistics as this avoids the reliance on the assumptions of
the underlying Chi-square approximation, which is par-
ticularly important when some allele pairs have small
counts [92]. An HWE score of 0 equates to the polymor-
phism being in complete Hardy-Weinberg equilibrium,
and a score of 1 equates to the polymorphism being in
complete Hardy-Weinberg disequilibrium. A standard
error (SE) for the estimated allele frequency for each SNP
was calculated by using the formula: SE = s/√n, where s is
the estimated standard deviation and n is the size of the
sample.
Weir and Cockerham FST test statistics [93] were calculated
for all SNP data as previously described [94] using R to
measure the effect of population subdivision and the
overall genetic divergence among these groups, where an
FST  of 0 means no genetic divergence, and 1 means
extreme genetic divergence, between the groups, and an
FST of up to 0.05 represents a relatively small level of
genetic differentiation. Weir and Cockerham FST test statis-
tics for the microsatellite data were calculated using FSTAT
version 2.9.3.2 [95]. To estimate the significance of these
FST values, a probability value (p) was calculated for each
FST value from a χ2 distribution using the pchisq function
in the Stats  R-package using 14 degrees of freedom
(number of Indian language groups minus 1) [96]. As it is
possible for the unbiased estimate of FST used here to
assume negative values, which does not have a biological
interpretation, we set negative values of FST to 0 [94].
As it was unrealistic to assume that the variance within the
Asian Indian cohort is equal to that of other populations,
a Welch modified two-sample t-test with unequal vari-
ances was calculated between the minor allele frequency
in the Indian cohort and those previously reported for
other populations. This was performed using the t.test
function in the Stats R-package with a 95% confidence
interval to test whether or not the minor allele frequency
in the Asian Indian cohort were significantly different
from those of other populations. To give as accurate a rep-
resentation of the MAF in the Asian Indian cohort, the
MAF of each group was included in this analysis. Data on
other populations was obtained from prior publications
and the National Center for Biotechnology Information's
(NCBI) dbSNP database [97,98]. These populations were
grouped into the following geographical regions for com-
parison: Africa, Asia (including Central, Southern, East-
ern, and South-East Asian populations), Americas (native
populations of South and Central America, and native
populations of North America), Europe (including non-
native European American populations, and Russia), Oce-
ania (Australia, New Zealand, and the Pacific islands),
except for the analysis of Cyp3A5 g.6980G>A and AGTBMC Genetics 2008, 9:13 http://www.biomedcentral.com/1471-2156/9/13
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g.802C>T where there were sufficient Asian populations
to allow Asia to be split into Central/South Asia and East
Asia (East and South-Eastern Asia), and there were also
sufficient populations to include a Middle East.
To test whether the polymorphisms associated with
atherosclerosis (ALOX5P and the three ALOX5  coding-
SNPs g.20C>T, g.8322G>A, and g.50778G>A), ability to
taste PTC (the three TAS2R38  coding-SNPs g.144G>C,
g.784C>T, and g.885A>G), and prostate cancer (the
DG8S737 microsatellite and rs1447295 SNP), were in
linkage disequilibrium, the linkage disequilibrium meas-
ure (D') and the squared correlation measure of linkage
disequilibrium (r2) were calculated between the respective
polymorphisms using the java based linkage disequilib-
rium plotter JLIN [99]. For the ALOX5P and DG8S737
microsatellite markers, each allele was tested individually
with all other alleles collapsed into a single "super-allele".
Adjusted Spearman's rank correlation coefficients and
squared correlation coefficients (r2) for the association of
the  CYP3A5  g.6980G>A,  AGT  g.802C>T, and GNB3
g.825C>T SNPs, and the TAS2R38 g.144G>C, g.784C>T,
and g.885A>G SNPs, with absolute latitude were calcu-
lated using SPSS version 15 (SPSS Inc.; Chicago, IL).
Graphs of their MAF against absolute latitude (Figures 2
&3) were plotted using SigmaPlot version 9 (Systat Soft-
ware, Inc.; San Jose, CA).
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